Egg phosphatidylcholine market is expected to observe a noteworthy growth rate over the coming seven years, driven by the increasing public awareness regarding health coupled with the growing demand for highly nutritious food. As per the report by Global Market Insights, Inc., “Egg Phosphatidylcholine Industry collected a revenue of over USD 8.9 million in 2015 and is anticipated to exhibit an annual growth rate of more than 5.5% over the coming period of 2016 to 2024.”
Phosphatidylcholine based medicines are prominently used for the treatment of various diseases such as tardive dyskinesia, hepatitis A, hepatitis C, ulcerative colitis, premenstrual syndrome, peritoneal dialysis, manic-depressive illness, eczema, and Alzheimer’s, which will stimulate egg phosphatidylcholine market size. This lucrative market growth can be attributed to the increasing product demand across the globe, owing to its capability to boost brain power and act as an anti-aging supplement.
Europe Egg Phosphatidylcholine Market size, by application, 2016 & 2024 (USD Million)
In terms of applications, Egg phosphatidylcholine industry is segmented into dietetics, cosmetics, and pharmaceuticals. The dietetics application is projected to register highest CAGR of more than 5.5% over the coming seven years. The growing consumption of the resources having choline as a primary content owing to the rising trends of health-consciousness and nutritious diet plans will stimulate market growth. To fulfill the increasing need of the egg phosphatidylcholine, many manufacturers are heavily investing in poultry farms, which will ultimately stimulate omega 3 ingredients market size.
The cosmetic application will generate a revenue of over USD 2.5 million by 2024, primarily driven by the increasing health consciousness among the youth regarding the benefits of natural constituents. Moreover, egg phosphatidylcholine is also used across a wide range of cosmetics products such as emulsifiers, solubilizers, and moisturizers, which are significantly used to nourish hair and skin.
The pharmaceutical application is projected to generate considerable revenue over the coming years. U.S. egg phosphatidylcholine market in pharmaceutical application collected a revenue of more than USD 330 million in 2015 and will be the major revenue contributor.
Considering the geographical landscape, China egg phosphatidylcholine industry is expected to surpass a revenue of USD 1.5 million by 2024, driven by the fact that aging people require more phosphatidylcholine to treat various diseases. China has a geriatric population of more than 20%, which will further drive market growth.
U.S. egg phosphatidylcholine market was worth around USD 2.5 million in 2015 and will exhibit significant growth rate over the coming years. The large number of U.S. population suffering from cardiovascular diseases (more than 30%) will augment the industry growth.
Germany egg phosphatidylcholine market share is predicted to record an annual growth rate of 3% over the period of 2016 to 2024, primarily driven by its surging demand for diabetic and anti-aging cosmetics. Additionally, most of the nutritionists and doctors prefer egg phosphatidylcholine for liver treatment, which will boost egg phosphatidylcholine industry size noticeably.
Market players are planning to improve the product portfolio to gain more profit over the coming years. The noteworthy participants in egg phosphatidylcholine market are Nutrasal, NOF America Corporation, Vitamin Research, Natural Factors, Avanti Polar Lipids, Inc., Kewpie Corp., Jena Bioscience GmbH, Vitamin Research Products, and Lipoid GmbH.